We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANVS icon
2926
Annovis Bio
ANVS
$76.6M
-3,000
Closed -$257K
ARDX icon
2927
Ardelyx
ARDX
$1.03B
-2,385,162
Closed -$18.1M
LONA
2928
LeonaBio Inc
LONA
$73.9M
-44,566
Closed -$4.56M
BBWI icon
2929
PUT
Bath & Body Works
BBWI
$3.65B
-20,287
Closed -$11.8M
BEEM icon
2930
Beam Global
BEEM
$25.8M
-6,822
Closed -$261K
BP icon
2931
BP
BP
$111B
-5,691,140
Closed -$150M
BZUN
2932
Baozun
BZUN
$164M
-7,600
Closed -$269K
CCRN
2933
DELISTED
Cross Country Healthcare
CCRN
-253,026
Closed -$4.18M
CLIR icon
2934
ClearSign Technologies
CLIR
$28.1M
-1,040
Closed -$50K
CLSD
2935
DELISTED
Clearside Biomedical
CLSD
-2,480
Closed -$181K
CTBI icon
2936
Community Trust Bancorp
CTBI
$1.42B
-14,666
Closed -$592K
DCO icon
2937
Ducommun
DCO
$3.04B
-3,825
Closed -$209K
DNTH icon
2938
Dianthus Therapeutics
DNTH
$6.29B
-1,410
Closed -$221K
DOYU
2939
DouYu International Holdings
DOYU
$138M
-2,270
Closed -$155K
DTIL icon
2940
Precision BioSciences
DTIL
$205M
-19,900
Closed -$7.47M
FINV
2941
FinVolution Group
FINV
$1.07B
-137,002
Closed -$1.3M
FLXS icon
2942
Flexsteel Industries
FLXS
$301M
-5,066
Closed -$205K
FVRR icon
2943
Fiverr
FVRR
$311M
-205,035
Closed -$49.7M
GLD icon
2944
SPDR Gold Trust
GLD
$144B
-1,400
Closed -$232K
GSBC icon
2945
Great Southern Bancorp
GSBC
$877M
-6,407
Closed -$345K
HURC icon
2946
Hurco Companies Inc
HURC
$144M
-5,900
Closed -$207K
HWBK icon
2947
Hawthorn Bancshares
HWBK
$276M
-14,850
Closed -$315K
IESC icon
2948
IES Holdings
IESC
$15.3B
-3,900
Closed -$200K
IGC icon
2949
IGC Pharma
IGC
$29.8M
-43,000
Closed -$71K
ILPT
2950
Industrial Logistics Properties Trust
ILPT
$605M
-22,139
Closed -$579K

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.